Evaluation of PF-07258669 in Older Adults at Risk of Malnutrition: A Clinical Trial

The primary objective of this study is to evaluate the properties of PF-07258669 in older adults, including individuals identified as being at risk of malnutrition. This investigation is intended to characterize the pharmacological profile of the compound within this specific demographic.

This study involves 56 healthy volunteers consisting of both male and female participants. The cohort is composed of older adults who are identified as being at risk of malnutrition. Information regarding the specific selection process, lifestyle considerations, or detailed inclusion and exclusion criteria was not provided by the sponsor.

This Phase 3 clinical trial evaluates the efficacy and safety of PF-07258669 in older adults, including individuals at risk of malnutrition. The research methodology involves a specific sequence of study visits beginning with a screening visit to determine eligibility. Following screening, participants undergo scheduled follow-up visits to monitor clinical outcomes, concluding with an end-of-study visit. The total duration of participant involvement is determined by the study protocol. Early termination from the study may occur based on predefined clinical conditions or safety criteria.

The assessment of efficacy in this clinical trial focuses on malnutrition risk among older adults. Specific parameters for evaluating the clinical impact and nutritional status are utilized to monitor disease progression and intervention response.